Is there a role for oral triple therapy in patients with acute coronary syndromes without atrial fibrillation? [PDF]
© 2018 Bentham Science PublishersBACKGROUND: Acute coronary syndrome (ACS) patients, despite treatment with dual antiplatelet therapy (DAPT), have up to 10% risk of recurrent major adverse cardiac events (MACE) in the short term.
Akhtar, Zaki +3 more
core +2 more sources
Myocardial Viability Testing in Patients with Ischemic Cardiomyopathy [PDF]
Ischemic cardiomyopathy (ICM) is an important cause of heart failure with reduced ejection fraction. Despite the improvement of treatment methods, it still has a high mortality.
SU Lifang, WANG Yanbo, JIANG Yunfa, LIU Changchang, GU Xinshun
doaj +1 more source
Increased hazard of myocardial infarction with insulin‐provision therapy in actively smoking patients with diabetes mellitus and stable ischemic heart disease: The BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial [PDF]
Background In the BARI 2D (Bypass Angioplasty Revascularization Investigation 2 Diabetes) trial, randomization of diabetic patients with stable ischemic heart disease to insulin provision ( IP
Brown, David L +3 more
core +2 more sources
Failed ISCHEMIA Trial or Failed Ischemia Testing? [PDF]
The results of the ISCHEMIA (International Study of Comparative Health Effectiveness With Medical and Invasive Approach) trial were presented at the American Heart Association Scientific Sessions in November, 2019 in Philadelphia, Pennsylvania, and ...
Budoff, Matthew J, Dahal, Suraj
core
A New Approach in Risk Stratification by Coronary CT Angiography. [PDF]
For a decade, coronary computed tomographic angiography (CCTA) has been used as a promising noninvasive modality for the assessment of coronary artery disease (CAD) as well as cardiovascular risks.
Budoff, Matthew J, Nakanishi, Rine
core +3 more sources
Integrated myocardial revascularization [PDF]
The integration of minimally invasive coronary artery bypass grafting with catheter-based interventions is being practiced with increasing frequency both in the standard and high risk patient populations. The procedures can be staged on different days or done concurrently in either an operative cathlab or an operating room with imaging capabilities ...
openaire +2 more sources
Myocardial protection during myocardial revascularization: Preductal®MR
Myocardial revascularization procedures (coronary artery bypass surgery, percutaneous coronary intervention) raise the question of protecting the myocardium. Trimetazidine is an adequate method of myocardial protection.
Editorial Article
doaj +1 more source
Many patients with non-ST elevation myocardial infarction have multivessel coronary artery disease, which complicates the course of the disease and is associated with fatal outcomes.
Sh. J. Khalilov, V. A. Azizov
doaj +1 more source
Myocardial revascularization in renal transplant patients
OBJECTIVE: To assess the results of surgical myocardial revascularization in renal transplant patients. METHODS: From 1991 to 2000, 11 renal transplant patients, whose ages ranged from 36 to 59 (47.5±8) years, 8 males and 3 females, underwent ...
Daniel de Souza Delgado +4 more
doaj +1 more source
Computational Modeling Meets 3D Bioprinting: Emerging Synergies in Cardiovascular Disease Modeling
Emerging advances in three‐dimensional bioprinting and computational modeling are reshaping cardiovascular (CV) research by enabling more realistic, patient‐specific tissue platforms. This review surveys cutting‐edge approaches that merge biomimetic CV constructs with computational simulations to overcome the limitations of traditional models, improve ...
Tanmay Mukherjee +7 more
wiley +1 more source

